Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Hernandez Joseph, Director. Officer active across 4 companies, notably Clarus Therapeutics INC. Cumulatively, 10 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €2.2m. Activity tracked since 9 September 2021. The latest transaction was filed on 18 August 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
10 of 10 declarations
Joseph Hernandez is a Board Member at Clarus Therapeutics Inc and Clarus Therapeutics Holdings, Inc. He plays a key role in overseeing the company's operations and strategy. With experience in the pharmaceutical sector, he contributes to Clarus's mission of developing innovative therapeutic solutions.